Bioactive Wound Care Market Report 2025

The bioactive wound care market size has grown strongly in recent years. It will grow from $7.6 billion in 2024 to $8.28 billion in 2025 at a compound annual growth rate (CAGR) of 9%. The growth in the historic period can be attributed to the rising prevalence of chronic wounds, increasing diabetic population, expanding geriatric population, higher incidence of surgical wound cases, and growing awareness among healthcare professionals.

The bioactive wound care market size is expected to see strong growth in the next few years. It will grow to $11.51 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to the increasing prevalence of chronic diseases, rising demand for advanced wound care solutions, growing adoption of bioactive dressings, expanding geriatric population, and higher healthcare expenditure. Major trends during this period include innovations in antimicrobial dressings, integration of smart wound dressings, adoption of technology for wound monitoring, advancements in growth factor applications, and developments in hydrogel-based dressings.

The increasing number of trauma cases is expected to propel the growth of the bioactive wound care market going forward. Trauma cases refer to physical injuries caused by external forces such as accidents, falls, or violence that often require urgent medical treatment. The rise in trauma cases is primarily driven by increasing road traffic accidents due to higher vehicle usage and inadequate road safety measures. Bioactive wound care supports trauma management by promoting faster healing, preventing infections, and enhancing tissue regeneration in complex or severe wounds. For instance, in December 2024, the Transport Accident Commission, an Australia-based government agency, reported 267 fatal crashes on Victorian roads in the 12 months to June 2024, an increase from 247 in the previous year. Therefore, the growing number of trauma cases is driving the expansion of the bioactive wound care market.

Key companies in the bioactive wound care market are developing innovative technologies, such as antimicrobial wound dressings, to improve infection control, accelerate healing, and reduce complications in chronic and acute wounds. Antimicrobial wound dressings are infused with agents like silver, iodine, or lidocaine to prevent microbial contamination, control infection, and relieve local pain, thereby supporting faster recovery. For example, in October 2024, Imbed Biosciences Inc., a US-based medical device company, received FDA 510(k) clearance for Microlyte Ag, a wound dressing that integrates antimicrobial silver and lidocaine to manage partial- and full-thickness wounds, providing both infection prevention and pain relief.

In May 2025, NovaBone Products LLC, a US-based biotechnology company specializing in bioactive wound care, partnered with Summit Products Group to expand U.S. distribution of the NovaForm Wound Matrix. This partnership aims to accelerate clinical adoption and increase access to advanced wound care solutions across outpatient and post-acute care settings. Summit Products Group is a US-based healthcare company focused on surgical and regenerative solutions.

Major players in the bioactive wound care market are 3M Company, Smith & Nephew PLC, Coloplast A/S, PAUL HARTMANN AG, Mölnlycke Health Care AB, CONVATEC GROUP PLC., Hollister Incorporated, Organogenesis Holdings Inc., DeRoyal Industries Inc., MiMedx Group Inc., B. Braun SE, Kerecis Inc., Sanara MedTech Inc., Aroa Biosurgery Limited, BioMonde GmbH, DermaRite Industries LLC., BSN MEDICAL PRIVATE LIMITED, Covalon Technologies Ltd., Sonoma Pharmaceuticals Inc., and Integra LifeSciences Holdings Corporation.

North America was the largest region in the bioactive wound care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bioactive wound care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the bioactive wound care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Bioactive wound care comprises a range of treatment solutions designed to enhance the body’s natural healing by delivering biologically active substances directly to the wound site. These solutions stimulate cellular activity, promote tissue regeneration, and aid in infection control, making them highly effective for chronic and complex wounds.

The primary types of bioactive wound care products include antimicrobial dressings, hydrogels, alginates, foams, collagen dressings, silver-based dressings, and hydrofiber dressings. Antimicrobial dressings are infused with agents such as silver or iodine to prevent or reduce infections while supporting healing. They function through antibacterial activity, anti-inflammatory effects, wound healing promotion, and moisture management. These products are commonly used for chronic wounds, acute wounds, burns, surgical wounds, diabetic foot ulcers, and pressure ulcers, and are utilized by hospitals, clinics, home care environments, ambulatory surgical centers, and nursing homes.

The bioactive wound care market research report is one of a series of new reports that provides bioactive wound care market statistics, including the bioactive wound care industry's global market size, regional shares, competitors with the bioactive wound care market share, detailed bioactive wound care market segments, market trends and opportunities, and any further data you may need to thrive in the bioactive wound care market. This bioactive wound care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bioactive wound care market consists of sales of bioengineered wound dressings, film dressings, and chitosan-based dressings. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.